Eur J Obstet Gynecol Reprod Biol. 2014 Aug;179:121-4. doi: 10.1016/j.ejogrb.2014.05.038. Epub 2014 Jun 4.
Franz MB1, Poterauer M1, Elhenicky M1, Stary S2, Birner P2, Vinatzer U3, Husslein P1, Streubel B4, Husslein H1.
Eur J Obstet Gynecol Reprod Biol
AbstractOBJECTIVE: To evaluate global and single gene methylation patterns as a sign for epigenetic modulation of the immune system in infants born by elective cesarean section (CS) and vaginal delivery (VD).STUDY DESIGN: For this prospective pilot study a two step approach was chosen. Initially 41 newborn infants comprising 23 delivered by VD and 18 delivered by elective CS were included. Global DNA methylation of umbilical cord blood was determined. In a second step, methylation status of 96 single genes linked to T cell activation, cytokine production, inflammatory response, and stem cell transcription was evaluated in 48 newborn infants, 20 delivered by VD and 28 delivered by CS.RESULTS: Global methylation did not differ significantly between CS and VD (p=0.732). The methylation status was low (threshold: =3%) for the majority of single genes (n=92) in both groups. FOXP3, CD7, ELA2, and IRF1 showed hypermethylation in both groups. In the CS group, ELA2 (p<0.001) and IRF1(p =0.017) showed significantly higher methylation compared to the VD group.CONCLUSION: We found no difference in global methylation between newborn infants in the VD group compared to the elective CS group. Methylation of single genes was significantly higher in newborn infants delivered by elective CS. Further research is needed to determine the significance of theses findings.Copyright © 2014. Published by Elsevier Ireland Ltd.
Full Text Source: Elsevier Science
PMID:24960239 | http://www.ncbi.nlm.nih.gov/pubmed/24960239